Birgit Keil

USPTO Granted Patents = 14 (Patent Applications = 14)

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 28)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Düsseldorf, DE (2012 - 2019)
Dusseldorf, DE (2016 - 2020)
Duesseldorf, DE (2018 - 2021)

Company Filing History:

Bayer Pharma Aktiengesellschaft

patents

2 out of 53

Aicuris Gmbh + Co. Kg.

Bayer Aktiengesellschaft

patents

6. 1 out of 721

Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12202805 - Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound (2025-01-21),

2. 12138256 - Treatment of cardiopulmonary disorders (2024-11-12),

3. 11203593 - Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate (2021-12-21),

4. 10676443 - Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile (2020-06-09),

5. 10662188 - Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate (2020-05-26),

6. 10336716 - Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide (2019-07-02),

7. 10316001 - Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile (2019-06-11),

8. 10087183 - Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate (2018-10-02),

9. 9957232 - 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate (2018-05-01),

10. 9926305 - Salts (2018-03-27),

11. 9637459 - Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents (2017-05-02),

12. 9340535 - N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate (2016-05-17),

13. 8466280 - Co-crystal compound of rivaroxaban and malonic acid (2013-06-18),

14. 8188270 - Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide (2012-05-29),

Title: Birgit Keil - Innovative Inventor from Düsseldorf

Introduction: Birgit Keil is a pioneering inventor based in Düsseldorf, Germany, known for her groundbreaking contributions to various fields.

Latest Patents: Birgit Keil holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Birgit Keil has been at the forefront of innovation, leading research teams and developing cutting-edge solutions to address global challenges.

Collaborations: Throughout her career, Birgit Keil has collaborated with leading universities, research institutions, and multinational companies to bring her inventions to life and make a positive impact on society.

Conclusion: Birgit Keil's passion for innovation and her dedication to creating a better future through her inventions make her a true inspiration in the world of technology and science.

This text is generated by artificial intelligence and may not be accurate.